That has led to an anti-obesity drug called Axokine, which is in the third and most important stage of clinical trials.

A Federal advisory panel today narrowly recommended that the first new anti-obesity drug in more than two decades be approved for sale.

Dr. Weintraub spent years working on anti-obesity drugs when he was in academia.

In the same issue, another article on Page 1 announced the approval of a new anti-obesity drug.

Some anti-obesity drugs can have severe, even, lethal side effects, fen-phen being a famous example.

Because of this, anti-obesity drugs are not a practical long-term solution for people who are overweight.

Overall, orlistat has been considered to be safer than other anti-obesity drugs.

If new psychostimulants and anti-obesity drugs appear in the future, she said, they will quickly take off.

From 1995 to 1996, sales of anti-obesity drugs nearly tripled to $526 million from $179 million.

These tried and true methods to fight fat will no doubt help us stay healthy without the potential side effects caused by anti-obesity drugs.